Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$48.64 - $62.51 $230,991 - $296,859
4,749 New
4,749 $266,000
Q3 2022

Nov 01, 2022

BUY
$57.96 - $78.12 $165,823 - $223,501
2,861 New
2,861 $202,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Richmond Brothers, Inc. Portfolio

Follow Richmond Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richmond Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richmond Brothers, Inc. with notifications on news.